Hostname: page-component-7c8c6479df-p566r Total loading time: 0 Render date: 2024-03-26T20:53:35.434Z Has data issue: false hasContentIssue false

Psychopharmacology and psychotherapy for the treatment of adults with ADHD—a systematic review of available meta-analyses

Published online by Cambridge University Press:  06 June 2013

Tais S. Moriyama*
Affiliation:
National Institute of Developmental Psychiatry for Children and Adolescents (INCT-CNPq), São Paulo, Brazil Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil Divison of Child and Adolescent Psychiatry, Department of Psychiatry, University of São Paulo Medical School, University of São Paulo, São Paulo, Brazil
Guilherme V. Polanczyk
Affiliation:
National Institute of Developmental Psychiatry for Children and Adolescents (INCT-CNPq), São Paulo, Brazil Divison of Child and Adolescent Psychiatry, Department of Psychiatry, University of São Paulo Medical School, University of São Paulo, São Paulo, Brazil
Fernanda S. Terzi
Affiliation:
Divison of Child and Adolescent Psychiatry, Department of Psychiatry, University of São Paulo Medical School, University of São Paulo, São Paulo, Brazil
Kauy M. Faria
Affiliation:
Divison of Child and Adolescent Psychiatry, Department of Psychiatry, University of São Paulo Medical School, University of São Paulo, São Paulo, Brazil
Luis A. Rohde
Affiliation:
National Institute of Developmental Psychiatry for Children and Adolescents (INCT-CNPq), São Paulo, Brazil Department of Psychiatry, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre, Brazil
*
*Address for correspondence: Tais S. Moriyama, Instituto Nacional de Psiquiatria do Desenvolvimento, Rua Dr. Ovídio Pires de Campos 785, 3° andar, CEAPESQ, sala 09, CEP 05403-010 - São Paulo, SP, Brazil. (Email taismoriyama@gmail.com)

Abstract

Objective/Introduction

Attention-deficit/hyperactivity disorder (ADHD) in adult life is a prevalent condition. We systematically reviewed the literature available by searching for meta-analyses assessing pharmacological and psychosocial interventions for adults with ADHD.

Methods

Using wide-ranging search terms, we retrieved 191 titles from the PubMed and Cochrane databases. Two independent evaluators judged all abstracts. Only meta-analyses about the treatment of adults with ADHD were included. Information from meta-analyses found was systematically extracted by 3 independent evaluators.

Results

Eight meta-analyses were identified. Results from those meta-analyses suggest that stimulants are effective in decreasing ADHD symptoms on a short-term basis with a medium to large effect size (ES). Short-acting stimulants might be superior to long-acting stimulants, but no data on difference in adherence are available for the comparison of these two types of formulation. Bupropion is superior to placebo but less effective than stimulants. No conclusions about the impact of psychosocial interventions can be drawn based on meta-analyses so far.

Discussion

The efficacy of stimulants in reducing ADHD symptoms for adults is well documented in meta-analyses, but there is a concerning lack of meta-analysis about other treatment interventions.

Conclusion

The available meta-analytic literature does not cover questions of essential clinical relevance for adults with ADHD.

Type
Review Articles
Copyright
Copyright © Cambridge University Press 2013 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Dr. Tais S. Moriyama receives financial support from the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Brazil.

References

1.Polanczyk, G, de Lima, MS, Horta, BL, Biederman, J, Rohde, LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007; 164(6): 942948.CrossRefGoogle ScholarPubMed
2.Lopez-Munoz, F, Alamo, C, Quintero-Gutierrez, FJ, Garcia-Garcia, P. A bibliometric study of international scientific productivity in attention-deficit hyperactivity disorder covering the period 1980–2005. Eur Child Adolesc Psychiatry. 2008; 17(6): 381391.CrossRefGoogle ScholarPubMed
3.Fayyad, J, De Graaf, R, Kessler, R, etal. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry. 2007; 190: 402409.CrossRefGoogle ScholarPubMed
4.Faraone, SV, Biederman, J, Mick, E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med. 2006; 36(2): 159165.CrossRefGoogle ScholarPubMed
5.Simon, V, Czobor, P, Balint, S, Meszaros, A, Bitter, I. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry. 2009; 194(3): 204211.CrossRefGoogle ScholarPubMed
6.Kessler, RC, Adler, L, Barkley, R, etal. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006; 163(4): 716723.CrossRefGoogle ScholarPubMed
7.Faraone, SV, Biederman, J. What is the prevalence of adult ADHD? Results of a population screen of 966 adults. J Atten Disord. 2005; 9(2): 384391.CrossRefGoogle ScholarPubMed
8.Schachter, HM, Pham, B, King, J, Langford, S, Moher, D. How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. Cmaj. 2001; 165(11): 14751488.Google ScholarPubMed
9.Faraone, SV, Biederman, J, Roe, C. Comparative efficacy of Adderall and methylphenidate in attention-deficit/hyperactivity disorder: a meta-analysis. J Clin Psychopharmacol. 2002; 22(5): 468473.CrossRefGoogle ScholarPubMed
10.Faraone, SV, Biederman, J. Efficacy of Adderall for Attention-Deficit/Hyperactivity Disorder: a meta-analysis. J Atten Disord. 2002; 6(2): 6975.CrossRefGoogle ScholarPubMed
11.Faraone, SV, Buitelaar, J. Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis. Eur Child Adolesc Psychiatry. 2010; 19(4): 353364.CrossRefGoogle ScholarPubMed
12.Connor, DF, Fletcher, KE, Swanson, JM. A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1999; 38(12): 15511559.CrossRefGoogle ScholarPubMed
13.Cheng, JY, Chen, RY, Ko, JS, Ng, EM. Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-meta-analysis and meta-regression analysis. Psychopharmacology (Berl). 2007; 194(2): 197209.CrossRefGoogle ScholarPubMed
14.Hazell, PL, Kohn, MR, Dickson, R, etal. Core ADHD symptom improvement with atomoxetine versus methylphenidate: a direct comparison meta-analysis. J Atten Disord. 2011; 15(8): 674683.CrossRefGoogle ScholarPubMed
15.Hanwella, R, Senanayake, M, de Silva, V. Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis. BMC Psychiatry. 2011; 11: 176.CrossRefGoogle ScholarPubMed
16.Klassen, A, Miller, A, Raina, P, Lee, SK, Olsen, L. Attention-deficit hyperactivity disorder in children and youth: a quantitative systematic review of the efficacy of different management strategies. Can J Psychiatry. 1999; 44(10): 10071016.CrossRefGoogle ScholarPubMed
17.Bjornstad, G, Montgomery, P. Family therapy for attention-deficit disorder or attention-deficit/hyperactivity disorder in children and adolescents. Cochrane Database Syst Rev. 2005(2): CD005042.Google ScholarPubMed
18.Majewicz-Hefley, A, Carlson, JS. A meta-analysis of combined treatments for children diagnosed with ADHD. J Atten Disord. 2007; 10(3): 239250.CrossRefGoogle ScholarPubMed
19.Van der Oord, S, Prins, PJ, Oosterlaan, J, Emmelkamp, PM. Efficacy of methylphenidate, psychosocial treatments and their combination in school-aged children with ADHD: a meta-analysis. Clin Psychol Rev. 2008; 28(5): 783800.CrossRefGoogle ScholarPubMed
20.Fabiano, GA, Pelham, WE Jr, Coles, EK, etal. A meta-analysis of behavioral treatments for attention-deficit/hyperactivity disorder. Clin Psychol Rev. 2009; 29(2): 129140.CrossRefGoogle ScholarPubMed
21.Zwi, M, Jones, H, Thorgaard, C, York, A, Dennis, JA. Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years. Cochrane Database Syst Rev. 2011(12): CD003018.Google ScholarPubMed
22.Storebo, OJ, Skoog, M, Damm, D, etal. Social skills training for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years. Cochrane Database Syst Rev. 2011(12): CD008223.Google ScholarPubMed
23.Faraone, SV. Using Meta-analysis to Compare the Efficacy of Medications for Attention-Deficit/Hyperactivity Disorder in Youths. P T. 2009; 34(12): 678694.Google ScholarPubMed
24.Faraone, SV, Biederman, J, Spencer, TJ, Aleardi, M. Comparing the efficacy of medications for ADHD using meta-analysis. MedGenMed. 2006; 8(4): 4.Google ScholarPubMed
25.Seixas, M, Weiss, M, Muller, U. Systematic review of national and international guidelines on attention-deficit hyperactivity disorder. J Psychopharmacol. 2012; 26(6): 753765.CrossRefGoogle ScholarPubMed
26.Ebert, D, Krause, J, Roth-Sackenheim, C. ADHS im Erwachsenenalter - Leitlinien auf der Basis eines Expertenkonsensus mit Unterstützung der DGPPN. Nervenarzt. 2003; 74: 939946.Google Scholar
27.Nutt, DJ, Fone, K, Asherson, P, etal. Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2007; 21(1): 1041.CrossRefGoogle ScholarPubMed
28. National Institute of Health and Clinical Excelence (NICE). Attention deficit hyperactivity disorder Diagnosis and management of ADHD in children, young people and adults. 2008 [cited 2012 12 September]; Available from: http://www.nice.org.uk/nicemedia/live/12061/42059/42059.pdf.Google Scholar
29. The Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA), Canadian ADHD Practice Guidelines, 2011, CADDRA: Toronto.Google Scholar
30.American Academy of Pediatrics (AAP). ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Pediatrics. 2011; 128(5): 10071022.CrossRefGoogle Scholar
31.Pliszka, S. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007; 46(7): 894921.CrossRefGoogle ScholarPubMed
32.Faraone, SV, Spencer, T, Aleardi, M, Pagano, C, Biederman, J. Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol. 2004; 24(1): 2429.CrossRefGoogle ScholarPubMed
33.Maneeton, N, Maneeton, B, Srisurapanont, M, Martin, SD. Bupropion for adults with attention-deficit hyperactivity disorder: meta-analysis of randomized, placebo-controlled trials. Psychiatry Clin Neurosci. 2011; 65(7): 611617.CrossRefGoogle ScholarPubMed
34.Verbeeck, W, Tuinier, S, Bekkering, GE. Antidepressants in the treatment of adult attention-deficit hyperactivity disorder: a systematic review. Adv Ther. 2009; 26(2): 170184.CrossRefGoogle ScholarPubMed
35.Peterson, K, McDonagh, MS, Fu, R. Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis. Psychopharmacology (Berl). 2008; 197(1): 111.CrossRefGoogle ScholarPubMed
36.Castells, X, Ramos-Quiroga, JA, Bosch, R, Nogueira, M, Casas, M. Amphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adults. Cochrane Database Syst Rev. 2011(6): CD007813.Google ScholarPubMed
37.Meszaros, A, Czobor, P, Balint, S, etal. Pharmacotherapy of adult attention deficit hyperactivity disorder (ADHD): a meta-analysis. Int J Neuropsychopharmacol. 2009; 12(8): 11371147.CrossRefGoogle ScholarPubMed
38.Faraone, SV, Glatt, SJ. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. J Clin Psychiatry. 2010; 71(6): 754763.CrossRefGoogle ScholarPubMed
39.Linderkamp, F, Lauth, G. The Efficacy of Pharmacological versus Psychotherapeutic Therapies in Adults with Attention Deficit/Hyperactivity Disorder (ADHD): An Empirical Meta-Analysis. Verhaltenstherapie. 2011; 21: 229238.CrossRefGoogle Scholar
40.Michielsen, M, Semeijn, E, Comijs, HC, etal. Prevalence of attention-deficit hyperactivity disorder in older adults in The Netherlands. Br J Psychiatry. 2012.CrossRefGoogle ScholarPubMed
41.Weiss, MD, Gadow, K, Wasdell, MB. Effectiveness outcomes in attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2006; 67(Suppl 8): 3845.Google ScholarPubMed
42.Marcus, SC, Wan, GJ, Kemner, JE, Olfson, M. Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med. 2005; 159(6): 572578.CrossRefGoogle ScholarPubMed
43.Winterstein, AG, Gerhard, T, Shuster, J, etal. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database. Ann Pharmacother. 2008; 42(1): 2431.CrossRefGoogle ScholarPubMed
44.Lawson, KA, Johnsrud, M, Hodgkins, P, Sasane, R, Crismon, ML. Utilization patterns of stimulants in ADHD in the Medicaid population: a retrospective analysis of data from the Texas Medicaid program. Clin Ther. 2012; 34(4): 944956; e4.CrossRefGoogle ScholarPubMed
45.Safren, SA, Sprich, S, Mimiaga, MJ, etal. Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. Jama. 2010; 304(8): 875880.CrossRefGoogle ScholarPubMed